Industry Prods Careful Debate on Creating Separate Rules for Leqembi Re-Pricing

Chuikyo Industry Hearing on Leqembi Pricing on Nov. 8 Japan’s reimbursement policy panel on November 8 held a hearing with three major pharma trade groups on the pricing of Leqembi (lecanemab), an Alzheimer’s therapy developed by Eisai. The focus of...read more